TWD 21.45
(-13.86%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.22 Billion TWD | 17.31% |
2022 | 1.04 Billion TWD | -3.95% |
2021 | 1.08 Billion TWD | -7.47% |
2020 | 1.17 Billion TWD | 11.04% |
2019 | 1.05 Billion TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 1.14 Billion TWD | -6.62% |
2024 Q2 | 1.14 Billion TWD | 0.0% |
2023 Q3 | 1.22 Billion TWD | 23.61% |
2023 FY | 1.22 Billion TWD | 17.31% |
2023 Q4 | 1.22 Billion TWD | 0.0% |
2023 Q2 | 991.62 Million TWD | 0.0% |
2023 Q1 | 991.62 Million TWD | -5.1% |
2022 Q4 | 1.04 Billion TWD | 0.0% |
2022 FY | 1.04 Billion TWD | -3.95% |
2022 Q3 | 1.04 Billion TWD | 0.0% |
2021 FY | 1.08 Billion TWD | -7.47% |
2020 FY | 1.17 Billion TWD | 11.04% |
2019 FY | - TWD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -857.239% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 57.747% |
Level Biotechnology Inc. | 822.67 Million TWD | -48.992% |
Sagittarius Life Science Corp | 664.72 Million TWD | -84.395% |
NeoCore Technology Co., Ltd. | 548.74 Million TWD | -123.366% |
TaiMed Biologics Inc. | 3.89 Billion TWD | 68.522% |
GlycoNex Incorporation | 1.55 Billion TWD | 21.065% |
VBI | 452.1 Million TWD | -171.115% |
GeneReach Biotechnology Corp. | 1.17 Billion TWD | -4.215% |
Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -63.741% |
SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -223.953% |
Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | -8.103% |
Visgeneer Inc. | 397.17 Million TWD | -208.608% |
Mycenax Biotech Inc. | 3.77 Billion TWD | 67.491% |
Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 43.228% |
G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | -38.798% |
Neith Corporation | 192.15 Million TWD | -537.885% |
Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 79.882% |
TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -1566.326% |
Enimmune corporation | 604.82 Million TWD | -102.656% |
TaiRx, Inc. | 833.74 Million TWD | -47.013% |
CHO Pharma, Inc. | 3.08 Billion TWD | 60.282% |
EirGenix Inc. | 11.16 Billion TWD | 89.019% |
BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -113.86% |
Sunny Pharmtech Inc. | 1.71 Billion TWD | 28.42% |
Lin BioScience, Inc. | 3.59 Billion TWD | 65.921% |
BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | -16.681% |
Feng Chi Biotech Corp. | 301.03 Million TWD | -307.171% |
Bio Preventive Medicine Corp. | 264.65 Million TWD | -363.134% |
Lukas Biomedical Inc. | 441.19 Million TWD | -177.82% |
RBC Bioscience Corporation | 753.79 Million TWD | -62.607% |
BiOptic Inc. | 613.77 Million TWD | -99.702% |
BRIM Biotechnology, Inc. | 1.77 Billion TWD | 31.088% |
Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | -5.691% |
Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -90.078% |
Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 60.54% |
Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -728.556% |
NaviFUS Corp. | 490.53 Million TWD | -149.873% |
Sinew Pharma Inc. | 1.36 Billion TWD | 10.097% |
Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -131.64% |
Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | -5.539% |
Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 25.996% |
AP Biosciences Inc | 890.75 Million TWD | -37.604% |
Medigen Biotechnology Corp. | 8.52 Billion TWD | 85.626% |
3D Global Biotech Inc. | 324.14 Million TWD | -278.135% |
Pharmosa Biopharm Inc. | 1.33 Billion TWD | 8.093% |
Intech Biopharm Corporation | 2.71 Billion TWD | 54.788% |
Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 92.022% |
Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -198.767% |
TWi Biotechnology, Inc. | 396.85 Million TWD | -208.861% |
Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 40.956% |
TCI GENE Inc. | 1.16 Billion TWD | -5.127% |
MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -316.088% |
Senhwa Biosciences, Inc. | 1.36 Billion TWD | 10.094% |
Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | -30.151% |
NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -75.491% |
PharmaEngine, Inc. | 3.95 Billion TWD | 69.0% |
Savior Lifetec Corporation | 3.82 Billion TWD | 67.936% |
TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 0.335% |
OBI Pharma, Inc. | 5.6 Billion TWD | 78.127% |
Meribank Biotech Co., Ltd | 1.06 Billion TWD | -15.415% |
Acepodia, Inc. | 6.81 Billion TWD | 82.024% |
Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 67.968% |